Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial

BACKGROUND AND PURPOSE: Frovatriptan is a selective 5-HT(1B/1D) agonist with a long duration of action and a low incidence of side effects. Although several placebo-controlled trials have documented the clinical efficacy and safety of frovatriptan in adults with migraine, this drug has not previousl...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Heui-Soo, Chu, Min Kyung, Park, Jeong Wook, Oh, Kyungmi, Chung, Jae Myun, Cho, Yong Jin, Kim, Eung Gyu, Do, Jin Kuk, Jung, Hyong Gi, Kwon, Sun Uck
Formato: Texto
Lenguaje:English
Publicado: Korean Neurological Association 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851296/
https://www.ncbi.nlm.nih.gov/pubmed/20386640
http://dx.doi.org/10.3988/jcn.2010.6.1.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851296/
https://www.ncbi.nlm.nih.gov/pubmed/20386640
http://dx.doi.org/10.3988/jcn.2010.6.1.27

Ejemplares similares